Compound-42 alleviates acute kidney injury by targeting RIPK3-mediated necroptosis. - He XY; Wang F; Suo XG; Gu MZ; Wang JN; Xu CH; Dong YH; He Y; Zhang Y; Ji ML; Chen Y; Zhang MM; et al. (British journal of pharmacology, 2023)